Adna Halilovic
New York Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Adna Halilovic.
Journal of Pharmacology and Experimental Therapeutics | 2009
Lars Bellner; Lucia Martinelli; Adna Halilovic; Kiran Patil; Nitin Puri; Michael W. Dunn; Raymond F. Regan; Michal Laniado Schwartzman
In previous studies, we have shown that heme oxygenase (HO)-2 null [HO-2(−/−)] mice exhibit a faulty response to injury; chronic inflammation and massive neovascularization replaced resolution of inflammation and tissue repair. Endothelial cells play an active and essential role in the control of inflammation and the process of angiogenesis. We examined whether HO-2 deletion affects endothelial cell function. Under basal conditions, HO-2(−/−) aortic endothelial cells (mAEC) showed a 3-fold higher expression of vascular endothelial growth factor receptor 1 and a marked angiogenic response compared with wild-type (WT) cells. Compared with WT cells, HO-2(−/−) mAEC showed a 2-fold reduction in HO activity and marked increases in levels of gp91phox/NADPH oxidase isoform, superoxide, nuclear factor κB activation, and expression of inflammatory cytokines, including interleukin (IL)-1α and IL-6. HO-2 deletion transforms endothelial cells from a “normal” to an “activated” phenotype characterized by increases in inflammatory, oxidative, and angiogenic factors. This switch may be the result of reduced HO activity and the associated reduction in the cytoprotective HO products, carbon monoxide and biliverdin/bilirubin, because addition of biliverdin to HO-2(−/−) cells attenuated angiogenesis and reduced superoxide production. This transformation underscores the importance of HO-2 in the regulation of endothelial cell homeostasis.
Journal of Cellular Physiology | 2011
Adna Halilovic; Kiran Patil; Lars Bellner; Giuseppina Marrazzo; Kirkland Castellano; Giuseppe Cullaro; Michael W. Dunn; Michal Laniado Schwartzman
Heme oxygenase (HO) represents an intrinsic cytoprotective system based on its anti‐oxidative and anti‐inflammatory properties mediated via its products biliverdin/bilirubin and carbon monoxide (CO). We showed that deletion of HO‐2 results in impaired corneal wound healing with associated chronic inflammatory complications. This study was undertaken to examine the role of HO activity and the contribution of HO‐1 and HO‐2 to corneal wound healing in an in vitro epithelial scratch injury model. A scratch wound model was established using human corneal epithelial (HCE) cells. These cells expressed both HO‐1 and HO‐2 proteins. Injury elicited a rapid and transient increase in HO‐1 and HO activity; HO‐2 expression was unchanged. Treatment with biliverdin or CORM‐A1, a CO donor, accelerated wound closure by 10% at 24 h. Inhibition of HO activity impaired wound closure by more than 50%. However, addition of biliverdin or CORM‐A1 reversed the effect of HO inhibition on wound healing. Moreover, knockdown of HO‐2 expression, but not HO‐1, significantly impaired wound healing. These results indicate that HO activity is required for corneal epithelial cell migration. Inhibition of HO activity impairs wound healing while amplification of its activity restores and accelerates healing. Importantly, HO‐2, which is highly expressed in the corneal epithelium, appears to be critical for the wound healing process in the cornea. The mechanisms by which it contributes to cell migration in response to injury may reside in the cytoprotective properties of CO and biliverdin. J. Cell. Physiol. 226: 1732–1740, 2011.
PLOS ONE | 2011
Giuseppina Marrazzo; Lars Bellner; Adna Halilovic; Giovanni Li Volti; Filippo Drago; Michael W. Dunn; Michal Laniado Schwartzman
Our studies demonstrated that Heme oxygenase (HO), in particular, the constitutive HO-2, is critical for a self-resolving inflammatory and repair response in the cornea. Epithelial injury in HO-2 null mice leads to impaired wound closure and chronic inflammation in the cornea. This study was undertaken to examine the possible relationship between HO-2 and the recruitment of neutrophils following a corneal surface injury in wild type (WT) and HO-2 knockout (HO-2−/−) mice treated with Gr-1 monoclonal antibody to deplete peripheral neutrophils. Epithelial injury was performed by removing the entire corneal epithelium. Infiltration of inflammatory cell into the cornea in response to injury was higher in HO-2−/− than in WT. However, the rate of corneal wound closure following neutrophil depletion was markedly inhibited in both WT and HO-2−/− mice by 60% and 85%, respectively. Neutropenia induced HO-1 expression in WT but not in HO-2−/− mice. Moreover, endothelial cells lacking HO-2 expressed higher levels of the Midkine and VE-cadherin and displayed strong adhesion to neutrophils suggesting that perturbation in endothelial cell function caused by HO-2 depletion underlies the increased infiltration of neutrophils into the HO-2−/− cornea. Moreover, the fact that neutropenia worsened epithelial healing of the injured cornea in both WT and HO-2−/− mice suggest that cells other than neutrophils contribute to the exaggerated inflammation and impaired wound healing seen in the HO-2 null cornea.
Investigative Ophthalmology & Visual Science | 2013
Adna Halilovic; Dao-Hong Lin; Gregory Joseph; Brian Shkolnik; Michal Laniado Schwartzman
Investigative Ophthalmology & Visual Science | 2013
Dao-Hong Lin; Adna Halilovic; Peng Yue; Lars Bellner; Kemeng Wang; Lijun Wang; Chengbiao Zhang
Molecular Vision | 2011
Lars Bellner; Kiran Patil; Kirkland Castellano; Adna Halilovic; Michael W. Dunn; Michal Laniado Schwartzman
Investigative Ophthalmology & Visual Science | 2013
Dao-Hong Lin; Adna Halilovic; Sherin Thomas; Kemeng Wang; Peng Yue; Lars Bellner
Investigative Ophthalmology & Visual Science | 2012
Adna Halilovic; Lars Bellner; Kirkland Castellano; Michael W. Dunn; Michal Laniado Schwartzman
Investigative Ophthalmology & Visual Science | 2011
Giuseppina Marrazzo; Lars Bellner; Adna Halilovic; Michael W. Dunn; Michal Laniado Schwartzman
Investigative Ophthalmology & Visual Science | 2010
Lars Bellner; Kiran Patil; Adna Halilovic; Kirkland Castellano; Giuseppe Cullaro; Michael W. Dunn; Michal Laniado Schwartzman